Full Year 2023 Investor Presentation slide image

Full Year 2023 Investor Presentation

15 Investor presentation Full year 2023 Attractive capital allocation to shareholders DKK billion 70 Annual cash return to shareholders 76 60 50 50 13 10 40 40 8 18 29 16 30 16 14 20 20 10 30 20 24 20 20 20 0 2021 2022 2023 Dividend Interim Dividend 2024E Share Repurchase Novo NordiskⓇ Capital allocation • Return of free cash flow through both share buybacks and dividends • For 2023, the total dividend per share increased 51.6% to DKK 9.40 (including interim dividend of DKK 3.00 per share paid in August 2023) • Final dividend for 2023 will be paid in March 2024 • The total capital allocation for 2023, through a combination of share buybacks and dividends, amounts to DKK 61.7 billion • For 2024, we expect to initiate a new 12-month share repurchase programme of up to DKK 20 billion Note: Share repurchase programmes run for 12 months starting in January. The total programme may be reduced in size if significant business development opportunities arise during 2024. The 2024E interim dividend included for illustrative purposes.
View entire presentation